daidzin has been researched along with hydrazine in 2 studies
| Studies (daidzin) | Trials (daidzin) | Recent Studies (post-2010) (daidzin) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
|---|---|---|---|---|---|
| 226 | 6 | 105 | 12,034 | 330 | 3,193 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrido, A; Muñoz, Y; Valladares, L | 1 |
| Beretta, M; Mayer, B; Schmidt, K; Stessel, H; Wenzl, MV; Wölkart, G | 1 |
2 other study(ies) available for daidzin and hydrazine
| Article | Year |
|---|---|
Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets.
Topics: Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Equol; Fatty Acids, Unsaturated; Genistein; Humans; Hydrazines; Isoflavones; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2 | 2009 |
Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin.
Topics: Aldehyde Dehydrogenase; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Biotransformation; Chloral Hydrate; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Tolerance; Enzyme Activation; Enzyme Inhibitors; Female; Guinea Pigs; Hydrazines; Injections, Subcutaneous; Isoflavones; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Time Factors; Vasodilation; Vasodilator Agents | 2009 |